The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAGENE | ADR | 005329107 | 4,739 | 264,000 | SH | SOLE | 264,000 | 0 | 0 | ||
| ALIGNMENT HEALTHCARE | COM | 01625V104 | 1,673,887 | 76,328,615 | SH | SOLE | 76,328,615 | 0 | 0 | ||
| CHINA INDEX HOLDINGS | SPNSRD ADS A | 16954W101 | 22,270 | 10,122,769 | SH | SOLE | 10,122,769 | 0 | 0 | ||
| FANG HOLDINGS | ADR | 30711Y300 | 13,883 | 1,110,644 | SH | SOLE | 1,110,644 | 0 | 0 | ||
| FUTU HLDGS LTD | SPON ADS CL A | 36118L106 | 522,253 | 3,288,333 | SH | SOLE | 3,288,333 | 0 | 0 | ||
| IMMUNOCORE | ADS | 45258D105 | 40,442 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| OAK STREET HEALTH | COM | 67181A107 | 3,725,373 | 68,645,164 | SH | SOLE | 68,645,164 | 0 | 0 | ||
| OPENDOOR | COM | 683712103 | 396,972 | 18,733,928 | SH | SOLE | 18,733,928 | 0 | 0 | ||
| PHARVARIS | ORD | N69605108 | 67,716 | 2,420,155 | SH | SOLE | 2,420,155 | 0 | 0 | ||
| ROYALTY PHARMA | SHS CLASS A | G7709Q104 | 65,430 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| WISH | CL A | 21077C107 | 266,838 | 16,888,478 | SH | SOLE | 16,888,478 | 0 | 0 | ||
| XP, INC | CL A | G98239109 | 1,740,454 | 46,202,650 | SH | SOLE | 46,202,650 | 0 | 0 | ||